Clinical Trial Update: TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

View source ↗

Summary

Clinical trial assessing the combination of transarterial chemoembolization (TACE) with an anti-PD-1 antibody for advanced hepatocellular carcinoma, focusing on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Status: RECRUITING